What's new

Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 9, Status: Authorised

Mar 27, 2025 - 17:25
 0
Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

New car review: The MGS5 EV is MG dealers' new star striker

Next Article

More than 80% of healthcare C-suites piloting genAI in pre-production, Accenture...

Related Posts

Medical devices

Medical devices

Feb 10, 2025  0

Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 12, 2025  0

Veterinary medicines European public assessment report (EPAR): Mhyosphere PCV ID, Mycoplasma hyopneumoniae and porcine circovirus vaccine (inactivated, recombinant), Status: Authorised

Veterinary medicines European public assessment report ...

Mar 14, 2025  0